Description and Brand Names
药物信息提供方:IBM Micromedex
US Brand Name
- Lagevrio
Descriptions
Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: March 01, 2023
版权 © 2023 IBM Watson Health。保留所有权利。信息仅供终端用户使用,不得出售、重新分发或用于其他商业目的。